TITLE

The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma

AUTHOR(S)
Stofas, Anastasios; Levidou, Georgia; Piperi, Christina; Adamopoulos, Christos; Dalagiorgou, Georgia; Bamias, Aristotelis; Karadimou, Alexandra; Lainakis, George A.; Papadoukakis, Stefanos; Stravodimos, Konstantinos; Dimopoulos, Meletios-Athanasios; Patsouris, Efstratios; Gakiopoulou, Hariklia; Korkolopoulou, Penelope
PUB. DATE
March 2014
SOURCE
BMC Cancer;2014, Vol. 14 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Chemokine receptor signaling pathways are implicated in the pathobiology of renal cell carcinoma (RCC). However, the clinical relevance of CXCR2 receptor, mediating the effects of all angiogenic chemokines, remains unclear. SOCS (suppressor of cytokine signaling)-3 is a negative regulator of cytokine-driven responses, contributing to interferon-α resistance commonly used to treat advanced RCC with limited information regarding its expression in RCC. Methods In this study, CXCR2 and SOCS-3 were immunohistochemically investigated in 118 RCC cases in relation to interleukin (IL)-6 and (IL)-8, their downstream transducer phosphorylated (p-)STAT-3, and VEGF expression, being further correlated with microvascular characteristics, clinicopathological features and survival. In 30 cases relationships with hypoxia-inducible factors, i.e. HIF-1a, p53 and NF-κB (p65/RelA) were also examined. Validation of immunohistochemistry and further investigation of downstream transducers, p-JAK2 and p-c-Jun were evaluated by Western immunoblotting in 5 cases. Results Both CXCR2 and IL-8 were expressed by the neoplastic cells their levels being interrelated. CXCR2 strongly correlated with the levels of HIF-1a, p53 and p65/RelA in the neoplastic cells. Although SOCS-3 was simultaneously expressed with p-STAT-3, its levels tended to show an inverse relationship with p-JAK-2 and p-c-Jun in Western blots and were positively correlated with HIF-1a, p53 and p65/p65/RelA expression. Neither CXCR2 nor SOCS-3 correlated with the extent of microvascular network. IL-8 and CXCR2 expression was associated with high grade, advanced stage and the presence/number of metastases but only CXCR2 adversely affected survival in univariate analysis. Elevated SOCS-3 expression was associated with progression, the presence/number of metastasis and shortened survival in both univariate and multivariate analysis. Conclusions Our findings implicate SOCS-3 overexpression in RCC metastasis and biologic aggressiveness advocating its therapeutic targeting. IL-8/CXCR2 signaling also contributes to the metastatic phenotype of RCC cells but appears of lesser prognostic utility. Both CXCR2 and SOCS-3 appear to be related to transcription factors induced under hypoxia.
ACCESSION #
94902641

 

Related Articles

  • Phosphorylated Signal Transducer and Activator of Transcription 1 is a potential predictor of interferon response in patients with advanced renal cell carcinoma. WEI LI; QIANG WEI; JIANBO LIANG // Molecular Medicine Reports;2014, Vol. 9 Issue 5, p1929 

    The present study aimed to evaluate the expression status of Janus kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) in renal cell carcinoma and benign renal tissue, and identify a potential biomarker for interferon (IFN) response prediction. A total of 32 specimens of human...

  • Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. Lin, Liguo; Zhong, Kaihua; Sun, Zhongkai; Wu, Guozhong; Ding, Guodong // Journal of Cancer Research & Clinical Oncology;Jan2012, Vol. 138 Issue 1, p11 

    Purpose: To explore the expression of receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB1) and their role in clear cell renal cell carcinoma (CCRCC) development and progression. Methods: Expression of RAGE and HMGB1 was examined in RCC using tissue...

  • Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma. Amend, B.; Hennenlotter, J.; Scharpf, M.; Kruck, S.; Kuehs, U.; Senger, E.; Merseburger, A.; Kuczyk, M.; Sievert, K.; Stenzl, A.; Bedke, J. // World Journal of Urology;Jun2012, Vol. 30 Issue 3, p353 

    Purpose: Renal oncocytomas are assigned as benign tumours, and their detailed molecular mechanism is poorly characterised. Activation of the PKB/Akt pathway is assumed to contribute to the pathogenesis and progression of malignant disease. For oncocytomas, hardly any data are available for Akt...

  • Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis. Lkhagvadorj, Sayamaa; Sung Soo Oh; Mi-Ra Lee; Jae Hung Jung; Hyun Chul Chung; Seung-Kuy Cha; Minseob Eom // Yonsei Medical Journal;Jun2014, Vol. 55 Issue 4, p861 

    Purpose: Both insulin and insulin-like growth factor (IGF)-1 signaling are key regulators of energy metabolism, cellular growth, proliferation, and survival. The IGF-1 receptor (IGF-1R) is overexpressed in most types of human cancers including renal cell carcinoma (RCC) with poor prognosis....

  • Targeted therapy for renal cell carcinoma: a new treatment paradigm. Hutson, Thomas E. // Baylor University Medical Center Proceedings;Jul2007, Vol. 20 Issue 3, p244 

    Metastatic clear cell renal cell cancer has traditionally been treated with cytokines (interferon or interleukin-2). Improved understanding of biology has engendered novel targeted therapeutic agents that have altered the natural history of this disease. The vascular endothelial growth factor...

  • High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma. An, H; Xu, L; Zhu, Y; Lv, T; Liu, W; Liu, Y; Liu, H; Chen, L; Xu, J; Lin, Z // British Journal of Cancer;4/29/2014, Vol. 110 Issue 9, p2261 

    Background:Aberrant CXC chemokine receptor 4 (CXCR4) expressions in malignant tissues have been reported; however, its role in kidney cancer prognosis remains unknown. The aim of this study was to determine the prognostic value of CXCR4 expression in patients with clear-cell renal cell carcinoma...

  • Hispidulin Potentiates the Antitumor Effect of Sunitinib Against Human Renal Cell Carcinoma in Laboratory Models. Gao, Hui; Jiang, Qixiao; Han, Yantao; Peng, Jianjun; Wang, Chunbo // Cell Biochemistry & Biophysics;Mar2015, Vol. 71 Issue 2, p757 

    The aim of the study was to evaluate the effect of the hispidulin, a naturally occurring flavonoid, in combination with a new multi-targeted oral medication, sunitinib on renal cell carcinoma (RCC) cell proliferation in vitro and on tumor growth in vivo. After treatment with hispidulin or...

  • Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis. Lkhagvadorj, Sayamaa; Sung Soo Oh; Mi-Ra Lee; Jae Hung Jung; Hyun Chul Chung; Seung-Kuy Cha; Minseob Eom // Yonsei Medical Journal;Jul2014, Vol. 55 Issue 4, p861 

    Purpose: Both insulin and insulin-like growth factor (IGF)-1 signaling are key regulators of energy metabolism, cellular growth, proliferation, and survival. The IGF-1 receptor (IGF-1R) is overexpressed in most types of human cancers including renal cell carcinoma (RCC) with poor prognosis....

  • PGE2 promotes renal carcinoma cell invasion through activated RalA. Li, Z; Zhang, Y; Kim, W J; Daaka, Y // Oncogene;3/14/2013, Vol. 32 Issue 11, p1408 

    Incidence of kidney cancer is on the rise, and a better understanding of molecular mechanisms involved in the cancer invasion and metastasis is required for the development of curative therapeutics. In this study, we report that the proinflammatory cytokine prostaglandin E2 (PGE2) induces the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics